º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Retail & Consumer

High street and travel store sales helps Boots offset slump in pharmacy sales

Impairment charges for º£½ÇÊÓÆµ operation helped drag US parent firm Walgreens Boots Alliance to significant loss

Boots the chemist

Sales from Boots high street and travel stores have helped offset declines in the firm’s pharmacy business.

It came as impairment charges for the º£½ÇÊÓÆµ operation helped drag its US parent firm Walgreens Boots Alliance (WBA) to a significant loss in the fourth quarter of its financial year.

WBA told investors on Thursday that it suffered loss per share of 48 cents for the three months to August, slipping from a profit a year earlier.

The group said it came after the Nottingham-headquartered Boots business was hit by a 783 million dollar (£695.5 million) non-cash impairment.

WBA reported that it saw like-for-like sales tumble 5.3% to 32.4 billion dollars (£32.8 billion) over the quarter, driven by declines at its US pharmacy operation.

In the º£½ÇÊÓÆµ, Boots revealed that retail sales grew by 15.2% over the three months to August, with trade recovering beyond pre-pandemic levels.

The retailer benefited from returning customers at city centres, airports and train stations.

Boots added that it witnessed surging sales of sunscreen amid the summer heatwave while the business also benefited from new beauty brand releases.